摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 3-(1,2:5,6-di-O-isopropylidene)-α-D-allofuranose ester | 1119518-72-7

中文名称
——
中文别名
——
英文名称
1-benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 3-(1,2:5,6-di-O-isopropylidene)-α-D-allofuranose ester
英文别名
[(3aR,5R,6R,6aR)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-yl] 1-benzyl-5-methyltriazole-4-carboxylate
1-benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 3-(1,2:5,6-di-O-isopropylidene)-α-D-allofuranose ester化学式
CAS
1119518-72-7
化学式
C23H29N3O7
mdl
——
分子量
459.499
InChiKey
XCMWMLFQJMACCH-POVPESKVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    97-98 °C
  • 沸点:
    579.3±60.0 °C(predicted)
  • 密度:
    1.42±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    33
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    103
  • 氢给体数:
    0
  • 氢受体数:
    9

反应信息

  • 作为反应物:
    描述:
    1-benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 3-(1,2:5,6-di-O-isopropylidene)-α-D-allofuranose ester三氟乙酸 作用下, 反应 48.0h, 生成 1-benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 3-D-allopyranose ester
    参考文献:
    名称:
    Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1H-1,2,3-triazole derivatives of carbohydrates
    摘要:
    This paper describes the synthesis of several 1-benzyl-1H-1,2,3-triazoles attached to different carbohydrate templates and their in vitro inhibitory profile against HIV-1 reverse transcriptase. In addition a theoretical comparison of the most active compounds with other classical antivirals was also performed. Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse transcriptase catalytic activity with cytotoxicity lower than AZT and SI higher than DDC and DDI. The overall theoretical analysis of the molecular descriptors of 2a, 2d and 2g revealed that their HOMO energy is similar to other antivirals in use (AZT, DDC, DDI and 3TC) and together with the volume may contribute for the biological profile as they may allow new interactions with the target. In fact the 1,2,3-triazole compounds presented more lipophilicity and higher molecular volume and weight than the antivirals studied, which suggested that these features might not only contribute for new interactions with the HIV-RT but also influence the specificity and consequently the low cytoxicity profile of these compounds. Thus these data point them as promising leading compounds for generating new anti-HIV-RT compounds. (C) 2008 Published by Elsevier Masson SAS.
    DOI:
    10.1016/j.ejmech.2008.02.047
  • 作为产物:
    描述:
    3-(benzylamino)but-2-enoic acid 3-(1,2:5,6-di-O-isopropylidene)-α-D-allofuranose ester 、 甲烷磺酰基叠氮化物 在 sodium hydride 作用下, 以 乙腈 为溶剂, 反应 48.0h, 以50%的产率得到1-benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid 3-(1,2:5,6-di-O-isopropylidene)-α-D-allofuranose ester
    参考文献:
    名称:
    Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1H-1,2,3-triazole derivatives of carbohydrates
    摘要:
    This paper describes the synthesis of several 1-benzyl-1H-1,2,3-triazoles attached to different carbohydrate templates and their in vitro inhibitory profile against HIV-1 reverse transcriptase. In addition a theoretical comparison of the most active compounds with other classical antivirals was also performed. Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse transcriptase catalytic activity with cytotoxicity lower than AZT and SI higher than DDC and DDI. The overall theoretical analysis of the molecular descriptors of 2a, 2d and 2g revealed that their HOMO energy is similar to other antivirals in use (AZT, DDC, DDI and 3TC) and together with the volume may contribute for the biological profile as they may allow new interactions with the target. In fact the 1,2,3-triazole compounds presented more lipophilicity and higher molecular volume and weight than the antivirals studied, which suggested that these features might not only contribute for new interactions with the HIV-RT but also influence the specificity and consequently the low cytoxicity profile of these compounds. Thus these data point them as promising leading compounds for generating new anti-HIV-RT compounds. (C) 2008 Published by Elsevier Masson SAS.
    DOI:
    10.1016/j.ejmech.2008.02.047
点击查看最新优质反应信息

文献信息

  • Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1H-1,2,3-triazole derivatives of carbohydrates
    作者:Fernando de C. da Silva、Maria Cecilia B.V. de Souza、Izabel I.P. Frugulhetti、Helena C. Castro、Silmara L. de O. Souza、Thiago Moreno L. de Souza、Diego Q. Rodrigues、Alessandra M.T. Souza、Paula A. Abreu、Fabiana Passamani
    DOI:10.1016/j.ejmech.2008.02.047
    日期:2009.1
    This paper describes the synthesis of several 1-benzyl-1H-1,2,3-triazoles attached to different carbohydrate templates and their in vitro inhibitory profile against HIV-1 reverse transcriptase. In addition a theoretical comparison of the most active compounds with other classical antivirals was also performed. Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse transcriptase catalytic activity with cytotoxicity lower than AZT and SI higher than DDC and DDI. The overall theoretical analysis of the molecular descriptors of 2a, 2d and 2g revealed that their HOMO energy is similar to other antivirals in use (AZT, DDC, DDI and 3TC) and together with the volume may contribute for the biological profile as they may allow new interactions with the target. In fact the 1,2,3-triazole compounds presented more lipophilicity and higher molecular volume and weight than the antivirals studied, which suggested that these features might not only contribute for new interactions with the HIV-RT but also influence the specificity and consequently the low cytoxicity profile of these compounds. Thus these data point them as promising leading compounds for generating new anti-HIV-RT compounds. (C) 2008 Published by Elsevier Masson SAS.
查看更多